Data on 927 diabetes patients showed those who took Gilead Sciences' angina drug Ranexa had 3.8 episodes of chest pain per week, while those who received a placebo experienced 4.3 per week. Ranexa-treated patients also required less nitroglycerin, researchers reported at the American College of Cardiology meeting.

Full Story:

Related Summaries